WHO ICTRP trial
Heart protection study
ISRCTN48489393 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN48489393 |
|---|---|
| Public title | Heart protection study |
| Primary sponsor | Medical Research Council (MRC) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Coronary heart disease (CHD) Circulatory System Chronic ischaemic heart disease |
| Interventions | Patients were randomised in a 2 x 2 factorial design to receive: 1. 40 mg simvastatin daily or matching placebo tablets 2. Antioxidant vitamins (vitamins E, C and beta-carotene) or matching placebo capsules Treatment duration was for five… |
| Registration date | Jun 4, 2000 |
| Target size | 20000 |
| Secondary IDs | G9123430 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: